ACRYSOF RESTOR
Report
- Report Number
- 1119421-2014-00553
- Event Type
- Injury
- Date Received
- July 22, 2014
- Date of Event
- January 6, 2014
- Report Date
- June 25, 2014
- Manufacturer
- ALCON RESEARCH, LTD./HUNTINGTON
- Product Code
- HQL
- PMA / PMN Number
- P040020
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- NOT APPLICABLE
Narratives
THE PRODUCT WAS NOT RETURNED. THE IOL PRODUCT HISTORY RECORDS WERE REVIEWED AND DOCUMENTATION INDICATES THE PRODUCT MET RELEASE CRITERIA. MONARCH PRODUCT HISTORY RECORD COULD NOT BE REVIEWED BECAUSE FACILITY DID NOT PROVIDE A LOT NUMBER OR ANY IDENTIFICATION TRACEABLE TO THE MANUFACTURING DOCUMENTATION. ROOT CAUSE HAS NOT BEEN IDENTIFIED. (B)(4).
EVALUATION SUMMARY: THE CUSTOMER INDICATED USE OF AN APPROVED CARTRIDGE WITH AN UNK HANDPIECE. IT IS UNK IF THE APPROVED COMPONENT OF THE VISCOELASTIC WAS USED. THIS REPORT WAS MAILED TO FDA ON 08/22/2014. THE MFR INTERNAL REF NUMBER IS: (B)(4).
MFR INTERNAL REF NUMBER IS (B)(4).
F/U REPORTS 01 AND 02 WERE SUBMITTED WITH INACCURATE MFR REPORT# 9612169-2014-00077. THE CORRECT NUMBER SHOULD MATCH THE INITIAL MDR AS 111421-2014-00553. THE MFR INTERNAL REF NUMBER IS: (B)(4)..
A CONSUMER REPORTED THAT AFTER AN IOL IMPLANTATION, SHE SAW A SPOT IN THE MIDDLE OF THE IOL (WHICH LOOKED LIKE A "PRETZEL"), A SHADOW AND DIFFICULTIES IN VISION. THE PATIENT CONSULTED ANOTHER DOCTOR TO GET A SECOND OPINION AND THAT DOCTOR DIAGNOSED A NEGATIVE DYSPHOTOPSIA. ADDITIONAL INFORMATION WAS PROVIDED BY THE SURGEON WHO CONFIRMED THAT ON THE RIGHT EYE, THERE IS A "PRETZEL" LIKE SHAPE PRESENT IN THE CENTRAL VISUAL FIELD. ON BOTH EYES, THERE IS PERIPHERAL LIMITATION, LIKE A FRAME. ACCORDING TO THE SURGEON, THE "FRAMES" ARE PROBABLY CAUSED BY THE CHANGE OF THE PERIPHERAL LIGHT PATH AT THE POSTERIOR CHAMBER LENS.
ADD'L INFO WAS PROVIDED BY THE SURGEON INDICATING THAT THE SPOT IN THE MIDDLE OF THE IOL DESCRIBED AS A "PRETZEL" WAS FIXED. NO CAUSE OR DIAGNOSIS WAS PROVIDED AS ACCORDING TO THE SURGEON FURTHER INVESTIGATIONS WERE REJECTED.
ADD'L INFO WAS RECEIVED FROM THE FACILITY WHO REPORTED THAT THE IOL WAS EXPLANTED AND ANOTHER IOL FROM ANOTHER MFR WAS IMPLANTED. AFTER THE EXPLANTATION ALL THE SYMPTOMS DISAPPEARED.
ADD'L RECEIVED FROM THE CONSUMER INDICATED THAT THE INITIAL SURGEON PRESCRIBED VITAMIN E TO TREAT THE VISUAL EVENTS. THE POSTERIOR CAPSULAR MEMBRANE WAS NOTED TO HAVE A FINE FOLD IN IT SIX MONTHS AFTER INITIAL LENS IMPLANTATION. THE SURGEON SHE SAW FOR A SECOND OPINION SUGGESTED THE LENS EXCHANGE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 427459 | ACRYSOF RESTOR | INTRAOCULAR LENS | HQL | ALCON RESEARCH, LTD./HUNTINGTON | SN6AD1 | 12173912 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other | MONARCH II "B" CARTRIDGES| DUOVISC| MONARCH IOL DELIVER SYSTEM HANDPIECE |